MELANIE HANEY: Open Payments
NPI 1851437859 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,447 in 152 payments from 20 companies in 2025. Trend: 2023 $2,501 · 2024 $3,920 · 2025 $3,447
Food & beverage: $3,377Education: $70
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $461 |
| ABBVIE INC. | 30 | $442 |
| UCB, Inc. | 13 | $352 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $319 |
| Lilly USA, LLC | 12 | $247 |
| Regeneron Healthcare Solutions, Inc. | 8 | $245 |
| Incyte Corporation | 10 | $237 |
| Janssen Biotech, Inc. | 9 | $234 |
| GENZYME CORPORATION | 4 | $190 |
| Novartis Pharmaceuticals Corporation | 6 | $143 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, OPZELURA, ILUMYA, EBGLYSS.
Industry payments across IN — which companies pay providers there.
